Hargraves MM, Richmond H, Morton R. Presentation of two bone marrow elements, the tart cell and the L.E. cell. Proc Staff Meet Mayo Clin 1948;23:25–8

Irure-Ventura J, López-Hoyos M. The past, present, and future in antinuclear antibodies (ANA). Diagnostics (Basel). 2022:12. Available from: https://pubmed.ncbi.nlm.nih.gov/35328200/ [cited 2023 11]

Irure-Ventura J, Rodríguez C, Vergara-Prieto E, Vargas ML, Quirant B, Jurado A, et al. Rare immunofluorescence patterns of autoantibodies on HEp-2 cells defined by ICAP identify different autoimmune diseases in the absence of associated specificities: a Spanish multicentre study. Rheumatology (Oxford). 2021;60:3904–12. Available from: https://pubmed.ncbi.nlm.nih.gov/33437990/ [cited 2023 Feb 11]

Article  PubMed  Google Scholar 

Im JH, Chung MH, Park YK, Kwon HY, Baek JH, Lee SY, et al. Antinuclear antibodies in infectious diseases. Infect Dis (Lond). 2020;52:177–85. Available from: https://pubmed.ncbi.nlm.nih.gov/31718355/ [cited 2023 Feb 11]

Article  CAS  PubMed  Google Scholar 

Damoiseaux J, Dotan A, Fritzler MJ, Bogdanos DP, Meroni PL, Roggenbuck D, et al. Autoantibodies and SARS-CoV2 infection: the spectrum from association to clinical implication: Report of the 15th Dresden Symposium on Autoantibodies. Autoimmun Rev. 2022;21 Available from: https://pubmed.ncbi.nlm.nih.gov/34896650/ [cited 2023 Feb 11]

Grygiel-Górniak B, Rogacka N, Rogacki M. Puszczewicz M. Antinuclear antibodies in autoimmune and allergic diseases. Reumatologia. 2017;55:298–304. Available from: https://pubmed.ncbi.nlm.nih.gov/29491538/ [cited 2023 Feb 11]

Article  PubMed  PubMed Central  Google Scholar 

Vlagea A, Falagan S, Gutiérrez-Gutiérrez G, Moreno-Rubio J, Merino M, Zambrana F, et al. Antinuclear antibodies and cancer: a literature review. Crit Rev Oncol Hematol. 2018;127:42–9. Available from: https://pubmed.ncbi.nlm.nih.gov/29891110/ [cited 2023 Feb 11]

Article  PubMed  Google Scholar 

Tan EM, Feltkamp TEW, Smolen JS, Butcher B, Dawkins R, Fritzler MJ, et al. Range of antinuclear antibodies in “healthy” individuals. Arthritis Rheum. 1997;40:1601–11. Available from: https://pubmed.ncbi.nlm.nih.gov/9324014/ [cited 2023 Feb 11]

Article  CAS  PubMed  Google Scholar 

Dinse GE, Parks CG, Weinberg CR, Co CA, Wilkerson J, Zeldin DC, et al. Increasing prevalence of antinuclear antibodies in the United States. Arthritis Rheumatol. 2020;72:1026–35. Available from: https://pubmed.ncbi.nlm.nih.gov/32266792/ [cited 2023 Feb 11]

Article  CAS  PubMed  PubMed Central  Google Scholar 

American College of Rheumatology Position Statement Subject: methodology of testing for antinuclear antibodies.

Martinez-Martinez L, Irure-Ventura J, Jurado A, Roy G, Montes MA, Barrios Y, et al. Laboratory and clinical practices in antinuclear antibody detection and related antigens: recommendations from a Spanish multicentre survey. Immunol Res. 2023;71 Available from: https://pubmed.ncbi.nlm.nih.gov/37195550/ [cited 2023 Sep 25]

Pérez D, Gilburd B, Azoulay D, Shovman O, Bizzaro N, Shoenfeld Y. Antinuclear antibodies: Is the indirect immunofluorescence still the gold standard or should be replaced by solid phase assays? Autoimmun Rev. 2018;17:548–52. Available from: https://pubmed.ncbi.nlm.nih.gov/29635079/ [cited 2023 Feb 11]

Article  PubMed  Google Scholar 

Orme ME, Andalucia C, Sjölander S, Bossuyt X. A hierarchical bivariate meta-analysis of diagnostic test accuracy to provide direct comparisons of immunoassays vs. indirect immunofluorescence for initial screening of connective tissue diseases. Clin Chem Lab Med. 2020;59:547–61. Available from: https://pubmed.ncbi.nlm.nih.gov/32352399/ [cited 2023 Feb 11]

Article  PubMed  Google Scholar 

Claessens J, Belmondo T, de Langhe E, Westhovens R, Poesen K, Hüe S, et al. Solid phase assays versus automated indirect immunofluorescence for detection of antinuclear antibodies. Autoimmun Rev. 2018;17:533–40. Available from: https://pubmed.ncbi.nlm.nih.gov/29526634/ [cited 2023 Feb 11]

Article  CAS  PubMed  Google Scholar 

Bizzaro N. Can solid-phase assays replace immunofluorescence for ANA screening? Ann Rheum Dis. 2020;79 Available from: https://pubmed.ncbi.nlm.nih.gov/30530824/ [cited 2023 Feb 11]

Bossuyt X, Claessens J, de Langhe E, Belmondo T, Westhovens R, Hue S, et al. Antinuclear antibodies by indirect immunofluorescence and solid phase assays. Ann Rheum Dis. 2020;79:E65. Available from: https://pubmed.ncbi.nlm.nih.gov/31076390/ [cited 2023 Feb 11]

Article  CAS  PubMed  Google Scholar 

Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78:1151–9. Available from: https://pubmed.ncbi.nlm.nih.gov/31383717/ [cited 2023 Feb 11]

Article  PubMed  Google Scholar 

Op De Beeck K, Vermeersch P, Verschueren P, Westhovens R, Mariën G, Blockmans D, et al. Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay. Autoimmun Rev. 2011;10:801–8. Available from: https://pubmed.ncbi.nlm.nih.gov/21741497/ [cited 2023 Feb 11]

Article  Google Scholar 

Willems P, De Langhe E, Claessens J, Westhovens R, Van Hoeyveld E, Poesen K, et al. Screening for connective tissue disease-associated antibodies by automated immunoassay. Clin Chem Lab Med. 2018;56:909–18. Available from: https://pubmed.ncbi.nlm.nih.gov/29306915/ [cited 2023 Feb 11]

Article  CAS  PubMed  Google Scholar 

Orme ME, Andalucia C, Sjölander S, Bossuyt X. A comparison of a fluorescence enzyme immunoassay versus indirect immunofluorescence for initial screening of connective tissue diseases: systematic literature review and meta-analysis of diagnostic test accuracy studies. Best Pract Res Clin Rheumatol. 2018;32:521–34. Available from: https://pubmed.ncbi.nlm.nih.gov/31174821/ [cited 2023 Feb 11]

Article  PubMed  Google Scholar 

Pashnina IA, Krivolapova IM, Fedotkina TV, Ryabkova VA, Chereshneva MV, Churilov LP, et al. Antinuclear autoantibodies in health: autoimmunity is not a synonym of autoimmune disease. Antibodies (Basel). 2021;10:1–26. Available from: https://pubmed.ncbi.nlm.nih.gov/33668697/ [cited 2023 Feb 11]

Google Scholar 

Xavier RM, Yamauchi Y, Nakamura M, Tanigawa Y, Ishikura H, Tsunematsu T, et al. Antinuclear antibodies in healthy aging people: a prospective study. Mech Ageing Dev. 1995;78:145–54. Available from: https://pubmed.ncbi.nlm.nih.gov/7596195/ [cited 2023 Feb 11]

Article  CAS  PubMed  Google Scholar 

Grygiel-Górniak B, Rogacka N, Puszczewicz M. Antinuclear antibodies in healthy people and non-rheumatic diseases — diagnostic and clinical implications. Reumatologia., 2018. 56:243–8. Available from: https://pubmed.ncbi.nlm.nih.gov/30237629/ [cited 2023 Feb 11]

Mahler M, Meroni PL, Bossuyt X, Fritzler MJ. Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. J Immunol Res. 2014; [cited 2023 Feb 11];2014. Available from: /pmc/articles/PMC4020446/

Martinez-Revuelta D, Irure-Ventura J, López-Hoyos M, Olmos JM, Pariente E, Martín-Millán M, et al. Comparison of ANA testing by indirect immunofluorescence or solid-phase assays in a low pre-test probability population for systemic autoimmune disease: the Camargo Cohort. Clin Chem Lab Med. 2023; [cited 2023 Feb 11]; Available from: https://pubmed.ncbi.nlm.nih.gov/36634098/

Fernandez SA, Lobo AZ, Oliveira ZN, Fukumori LM, Périgo AM, Rivitti EA. Prevalence of antinuclear autoantibodies in the serum of normal blood dornors. Rev Hosp Clin Fac Med Sao Paulo. 2003;58:315–9. Available from: https://pubmed.ncbi.nlm.nih.gov/14762490/

Article  PubMed  Google Scholar 

Meier HCS, Sandler DP, Simonsick EM, Weng N, Parks CG. Sex differences in the association between antinuclear antibody positivity with diabetes and multimorbidity in older adults: results from the Baltimore Longitudinal Study of Aging. Exp Gerontol. 2020;135:110906.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martínez J, Olmos JM, Hernández JL, Pinedo G, Llorca J, Obregón E, et al. Bone turnover markers in Spanish postmenopausal women: the Camargo cohort study. Clin Chim Acta. 2009;409:70–4. Available from: https://pubmed.ncbi.nlm.nih.gov/19737549/ [cited 2022 Oct 2]

Article  PubMed  Google Scholar 

Olmos JM, Hernández JL, García-Velasco P, Martínez J, Llorca J, González-Macías J. Serum 25-hydroxyvitamin D, parathyroid hormone, calcium intake, and bone mineral density in Spanish adults. Osteoporos Int. 2016;27:105–13. Available from: https://pubmed.ncbi.nlm.nih.gov/26134682/ [cited 2022 Oct 2]

Article  CAS  PubMed  Google Scholar 

Hernández JL, Olmos JM, Pariente E, Martínez J, Valero C, García-Velasco P, et al. Metabolic syndrome and bone metabolism: the Camargo Cohort Study. Menopause. 2010;17:955–61. Available from: https://journals.lww.com/menopausejournal/Fulltext/2010/17050/Metabolic_syndrome_and_bone_metabolism__the.14.aspx [cited 2022 Oct 2]

Article  PubMed  Google Scholar 

Olmos JM, Hernández JL, Pariente E, Martínez J, Valero C, González-Macías J. Trabecular bone score and bone quantitative ultrasound in Spanish postmenopausal women. The Camargo Cohort Study. Maturitas. 2020;132:24–9. Available from: https://pubmed.ncbi.nlm.nih.gov/31883659/ [cited 2022 Oct 2]

Article  CAS  PubMed  Google Scholar 

Leuchten N, Hoyer A, Brinks R, Schoels M, Schneider M, Smolen J, et al. Performance of antinuclear antibodies for classifying systemic lupus erythematosus: a systematic literature review and meta-regression of diagnostic data. Arthritis Care Res (Hoboken). 2018;70:428–38. Available from: https://pubmed.ncbi.nlm.nih.gov/28544593/ [cited 2023 Sep 25]

Article  CAS  PubMed  Google Scholar 

Chan EKL, Damoiseaux J, Carballo OG, Conrad K, de Melo CW, Francescantonio PLC, et al. Report of the First International Consensus on Standardized Nomenclature of Antinuclear Antibody HEp-2 cell patterns 2014-2015. Front Immunol. 2015:6. Available from: https://pubmed.ncbi.nlm.nih.gov/26347739/ [cited 2022 Nov 22]

Andrade LEC, Klotz W, Herold M, Conrad K, Rönnelid J, Fritzler MJ, et al. International consensus on antinuclear antibody patterns: definition of the AC-29 pattern associated with antibodies to DNA topoisomerase I. Clin Chem Lab Med. 2018;56:1783–8. Available from: https://pubmed.ncbi.nlm.nih.gov/29813025/ [cited 2022 Nov 22]

Article  CAS  PubMed  Google Scholar 

Satoh M, Chan EKL, Ho LA, Rose KM, Parks CG, Cohn RD, et al. Prevalence and sociodemographic correlates of antinuclear antibodies in the United States. Arthritis Rheum. 2012;64:2319–27.

Article  PubMed  PubMed Central  Google Scholar 

Marin GG, Cardiel MH, Cornejo H, Viveros ME. Prevalence of antinuclear antibodies in 3 groups of healthy individuals: blood donors, hospital personnel, and relatives of patients with autoimmune diseases. J Clin Rheumatol. 2009;15:325–9. Available from: https://pubmed.ncbi.nlm.nih.gov/20009966/ [cited 2023 Feb 12]

Article  PubMed  Google Scholar 

Hayashi N, Koshiba M, Nishimura K, Sugiyama D, Nakamura T, Morinobu S, et al. Prevalence of disease-specific antinuclear antibodies in general population: estimates from annual physical examinations of residents of a small town over a 5-year period. Mod Rheumatol. 2008;18:153–60. Available from: https://pubmed.ncbi.nlm.nih.gov/18283522/ [cited 2023 Feb 12]

Article  CAS  PubMed  Google Scholar 

Ruffatti A, Rossi L, Calligaro A, Del Ross T, Lagni M, Marson P, et al. Autoantibodies of systemic rheumatic diseases in the healthy elderly. Gerontology. 1990;36:104–11. Available from: https://pubmed.ncbi.nlm.nih.gov/2376330/ [cited 2023 Feb 12]

Article  CAS  PubMed  Google Scholar 

Nilsson BO, Skogh T, Ernerudh J, Johansson B, Löfgren S, Wikby A, et al. Antinuclear antibodies in the oldest-old women and men. J Autoimmun. 2006;27:281–8. Available from: https://pubmed.ncbi.nlm.nih.gov/17156973/ [cited 2023 Feb 12]

Article  CAS  PubMed  Google Scholar 

Hurme M, Korkki S, Lehtimäki T, Karhunen PJ, Jylhä M, Hervonen A, et al. Autoimmunity and longevity: presence of antinuclear antibodies is not associated with the rate of inflammation or mortality in nonagenarians. Mech Ageing Dev. 2007;128:407–8. Available from: